Healthcare | May 08, 2024
Sumitomo Corporation makes full-scale entry into private clinic business in fast-growing southeast Asia
Investing in Malaysia's largest clinic operator to expand the healthcare business
Investing in Malaysia's largest clinic operator to expand the healthcare business
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Five batches across four programs of Biocon Academy participated in the graduation ceremony
10+ emerging markets, Japan & ANZ transition in final phase
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022
The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field
Subscribe To Our Newsletter & Stay Updated
